Not available here in the US yet, but this is a genomic based test that is cancer specific. Nobody likes having a biopsy done by any means and this appears to be working in that direction, in other words more information available to perhaps avoid biopsies that are perhaps not required. BD...
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
on 08-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test